Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLGS Functionality in AID System for T1DM
NCT03890003Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2019
- Primary completion
- May 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial in type 1 diabetes mellitus (T1D), sponsored by Eli Lilly and Company. Primary endpoints: Number of Adverse Events (AEs) at 2 days and Continuous Glucose Monitor (CGM) Measured Percentage of Time <70 mg/dL at 2 days. Started Mar 2019; status: completed.
02
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03890003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03890003.